Intravascular lymphoma: a role for single-agent rituximab
- 1 January 2006
- journal article
- case report
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 47 (2), 337-341
- https://doi.org/10.1080/10428190500300837
Abstract
Intravascular lymphoma is a rare aggressive systemic neoplasm with neurological and cutaneous presentation, which commonly eludes the diagnosis ante mortem. We document a case of intravascular lymphoma in a 65-year-old man who presented with altered mental status, fevers and weight loss. The diagnosis was made by random skin biopsies demonstrating an intravascular, CD20 positive cellular infiltrate. Initial treatment consisted of cyclophosphamide, vincristine, doxorubicin, prednisone and rituximab. Because of disease progression, the therapy was switched to weekly rituximab after the first cycle. A complete response was observed with resolution of symptoms and laboratory abnormalities. The patient remains in remission 3 years after completion of therapy. This is the first case report to describe a sustained remission following single-agent rituximab in the patient with neurologic involvement of intravascular lymphoma who failed antracycline-based therapy. Single-agent rituximab has activity in this disease and may be considered as a treatment option.This publication has 22 references indexed in Scilit:
- First Reported Cases of Intravascular Large Cell Lymphoma of the NK Cell TypeAmerican Journal of Clinical Pathology, 2005
- Linfoma intravascular tratado con anticuerpos monoclonales anti CD20: Descripción de un caso clínicoRevista médica de Chile, 2004
- Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1British Journal of Haematology, 2004
- Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapyAnnals of Hematology, 2004
- Intravascular Lymphoma Presenting as Telangectasias: Response to Rituximab and Combination ChemotherapyJournal of Cutaneous Medicine and Surgery, 2003
- Intravascular Lymphoma Presenting with Cauda Equina Syndrome: Treated with CHOP and RituxanLeukemia & Lymphoma, 2003
- Four varied cases of intravascular lymphomatosis and a literature reviewCancer, 1994
- Angiotropic large cell lymphoma (ALCL): Morphological, immunohistochemical and genotypic studies with analysis of previous reportsHematological Oncology, 1989
- Further Evidence That Malignant Angioendotheliomatosis Is an Angiotropic Large-Cell LymphomaThe New England Journal of Medicine, 1986
- Reassessment of Malignant “Angioendotheliomatosis”The American Journal of Surgical Pathology, 1986